Aptagen updated its library of products to include over 300 custom-order aptamer sequences. This network of sequences can be used in applications including drug discovery, therapeutics, and diagnostic and biomarker tools. Due to their production times and batch-to-batch consistency, aptamers are becoming a viable alternative to traditional antibodies. The benefits continue post-synthesis too, as aptamers exhibit higher binding affinity and specificity than antibodies. Aptagen’s library of sequences can be used for targeting small organics, peptides, proteins, viruses, cells, and bacteria.

Aptagen LLC, 717-278-2436, www.aptagen.com